English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51966051    線上人數 :  1049
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 741116-741140 / 2348419 (共93937頁)
<< < 29640 29641 29642 29643 29644 29645 29646 29647 29648 29649 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
亞洲大學 2007.03 Safety Sexual Behaviors in Asia University 黃英家;Huang, Ying-Chia
國立臺灣海洋大學 2012-08-01 Safety stock estimation of unit load devices for international airline operations Hua-An Lu ; Chien-Yi Chen
臺北醫學大學 2010 Safety studies and related topic on food with nanoparticles YW, Cheng
臺北醫學大學 2010 Safety studies and related topic on food with nanoparticles Cheng, YW
國立臺灣大學 1959 Safety Study in Industrial Management 黃玉池
臺大學術典藏 2021-10-27T02:13:53Z Safety surveillance of varicella vaccine using tree-temporal scan analysis Liu, Chia-Hung; Huang, Wan-Ting; WEI-CHU CHIE; Arnold Chan, K
臺大學術典藏 2022-05-05T09:09:56Z Safety surveillance of varicella vaccine using tree-temporal scan analysis Liu C.-H.; Huang W.-T.; WEI-CHU CHIE; Arnold Chan K.
國立成功大學 2022-03-01 Safety Time and Optimal Temperature of Unilateral Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection: A Single-Center 15- Year Experience 阮俊能; ROAN, JUN-NENG; Tsai, Meng-Ta;Wu, Hsuan-Yin;Hu, Yu-Ning;Lin, Ting-Wei;Wen, Jih-Sheng;Luo, Chwan-Yau;Roan, Jun-Neng
國立成功大學 2022-03 Safety Time and Optimal Temperature of Unilateral Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection: A Single-Center 15-Year Experience Tsai;Meng-Ta;Wu;Hsuan-Yin;Hu;Yu-Ning;Lin;Ting-Wei;Wen;Jih-Sheng;Luo;Chwan-Yau;Roan;Jun-Neng
臺大學術典藏 2020-01-03T06:13:49Z Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers Hsu A.-P.; Tseng C.-H.; Barrat J.; Lee S.-H.; Shih Y.-H.; Wasniewski M.; M?hl P.; Chang C.-C.; Lin C.-T.; Chen R.-S.; Tu W.-J.; Cliquet F.; Tsai H.-J.; HSIANG-JUNG TSAI
臺大學術典藏 2021-04-23T05:56:27Z Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial Chih-Hsin Yang;Camidge D.R.;Yang C.-T.;Zhou J.;Guo R.;Chiu C.-H.;Chang G.-C.;Shiah H.-S.;Chen Y.;Wang C.-C.;Berz D.;Su W.-C.;Yang N.;Wang Z.;Fang J.;Chen J.;Nikolinakos P.;Lu Y.;Pan H.;Maniam A.;Bazhenova L.;Shirai K.;Jahanzeb M.;Willis M.;Masood N.;Chowhan N.;Hsia T.-C.;Jian H.;Lu S.; CHIH-HSIN YANG; Camidge D.R.; Yang C.-T.; Zhou J.; Guo R.; Chiu C.-H.; Chang G.-C.; Shiah H.-S.; Chen Y.; Wang C.-C.; Berz D.; Su W.-C.; Yang N.; Wang Z.; Fang J.; Chen J.; Nikolinakos P.; Lu Y.; Pan H.; Maniam A.; Bazhenova L.; Shirai K.; Jahanzeb M.; Willis M.; Masood N.; Chowhan N.; Hsia T.-C.; Jian H.; Lu S.
國立成功大學 2020 Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial Yang, J.C.-H.;Camidge, D.R.;Yang, C.-T.;Zhou, J.;Guo, R.;Chiu, Chiu C.-H.;Chang, G.-C.;Shiah, H.-S.;Chen, Y.;Wang, C.-C.;Berz, D.;Su, W.-C.;Yang, N.;Wang, Z.;Fang, J.;Chen, J.;Nikolinakos, P.;Lu, Y.;Pan, H.;Maniam, A.;Bazhenova, L.;Shirai, K.;Jahanzeb, M.;Willis, M.;Masood, N.;Chowhan, N.;Hsia, T.-C.;Jian, H.;Lu, S.
國立成功大學 2024-10-10 Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial Yao;Herui;Yan;Min;Tong;Zhongsheng;Wu;Xinhong;Ryu;Min-Hee;Park;John, John J.;Kim;Hyun, Jee;Zhong;Yahua;Zhao;Yiming;Voskoboynik;Mark;Yin;Yongmei;Liu;Kan;Kaubisch;Andreas;Liu;Caigang;Zhang;Jian;Wang;Shouman;Im;Seock-Ah;Ganju;Vinod;Barve;Minal;Li;Hui;Ye;Changsheng;Roy;Amitesh, C.;Bai;Li-Yuan;Yen;Chia-Jui;Gu;Shanzhi;Lin;Yung-Chang;Wu;Lingying;Bao;Lequn;Zhao;Kaijing;Shen;Yu;Rong;Shangyi;Zhu;Xiaoyu;Song;Erwei
臺大學術典藏 2021-10-21T23:28:04Z Safety, feasibility, and effects of short-term calorie reduction during induction chemotherapy in patients with diffuse large b-cell lymphoma: A pilot study CHIA-CHUN TANG; TAI-CHUNG HUANG; Tien, Feng Ming; Lin, Jing Meei; Yeh, Yi Chen; Lee, Ching Yi
臺大學術典藏 2022-04-14T07:20:22Z Safety, feasibility, and effects of short-term calorie reduction during induction chemotherapy in patients with diffuse large b-cell lymphoma: A pilot study Tang C.-C.; Huang T.-C.; FENG-MING TIEN; Lin J.-M.; Yeh Y.-C.; Lee C.-Y.
臺大學術典藏 2022-05-02T02:02:03Z Safety, feasibility, and effects of short-term calorie reduction during induction chemotherapy in patients with diffuse large b-cell lymphoma: A pilot study CHIA-CHUN TANG; Huang T.-C.; Tien F.-M.; Lin J.-M.; Yeh Y.-C.; Lee C.-Y.
國立成功大學 2006-04 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study Lee, K. S.; Lim, S. G.; Chuang, W. L.; Hwang, S. G.; Cho, M.; Lai, M. Y.; Chao, Y. C.; Chang, Ting-Tsung; Han, K. H.; Lee, C. M.; Um, S. H.; Yeon, J. E.; Yang, S. S.; Teo, E. K.; Peng, C. Y.; Lin, H. H.; Huo, T. I.; T. Nguyen; Chen, T. Y.; Hu, K. Q.; Xu, Y.; J. Z. Sullivan-Bólyai; Lee, K. S.
高雄醫學大學 2006 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis b virus infection: 48-week analysis of a phase 2 study  Lee, KS;Lim, SG;莊萬龍;Hwang, SG;Cho, M;Lai, MY;Chao, YC;Chang, TT;Han, KH;Lee, CM;Um, SH;Yeon, JE;Yang, SS;Teo, EK;Peng, CY;Lin, HH;Yang, SS;Huo , TI
國立成功大學 2021 Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH) Song, J.-Y.;Chang, Chang C.-J.;Andrews, C.;Diez-Domingo, J.;Oh, M.-D.;Dagan, R.;Hartzel, J.;Pedley, A.;Li, J.;Sterling, T.;Tamms, G.;Chiarappa, J.A.;Lutkiewicz, J.;Musey, L.;Tu, Y.;Buchwald, U.K.
國立臺灣科技大學 2017 Safety-culture exploration in Taiwan's metal industries: identifying theworkers' background influence on safety climate Lin, S.-C.;Mufidah, I.;Persada, S.F.
中原大學 2008-10-17 Safety-First Portfolio Linear Program Using Sampled Tail Distribution Kuo-Hwa Chang;Yu-Lin Chiang;Yang-Shu Lu;
中原大學 2007-12 Safety-First Portfolio Optimization Problem Using Approximated Tail Distribution Chang, Kuo-Hwa;Chiang, Yu-Lin;Wei, Ming-Kuan;Chou, Yu-Ting
中原大學 2007-10 Safety-First Portfolio Optimization Problem Using Approximated Tail Distribution Chang, Kuo-Hwa;Chiang, Yu-Lin;Wei, Ming-Kuan;Chou, Yu-Ting
中原大學 2006-12 Safety-First Portfolio Selection Problem Using Extreme Value Theory for the Estimating Risk Chang, Kuo-Hwa;Lin, Tzu-Li;Wei, Ming-Kuan
中國醫藥大學 2009-11 Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer’s Disease (Pai-Yi Chiu)*; 戴道恩(Peterus THAJEB); (hai-pei hsu); (chao lee); (juei-jueng lin); (hung-chou kuo); (ying-chin huang); (yung-chang liu); (ching-piao tsai)

顯示項目 741116-741140 / 2348419 (共93937頁)
<< < 29640 29641 29642 29643 29644 29645 29646 29647 29648 29649 > >>
每頁顯示[10|25|50]項目